Lasmiditan is a promising treatment for menstrual migraine, offering sustained pain relief comparable to or exceeding that of triptans. However, further research is needed to fully assess its safety ...

A new study of a migraine-specific tool reveals that patients are most concerned about misconceptions about migraine and the ...

Discover what your headache is telling you. Learn to identify and manage tension headaches, migraines, cluster headaches, and ...

The American College of Physicians issues new guidance on the prevention of episodic migraine with pharmacologic treatment recommendations.

Atogepant vs placebo for the preventative treatment of migraine alleviated migraine symptoms across 3 clinical trials on day 1.

Researchers evaluated the global rates of incidence, prevalence, and disability-adjusted life years of migraine from 1990 to 2021.

Having a headache is one thing, but adding other symptoms on top of that like new vision changes, numbness, tingling, ...

Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...

Research reveals howneurogenic connection can directly trigger inflammatory processes, creating pain patterns that challenge ...

Dr. Archelle Georgiou joined 5 EYEWITNESS NEWS on Wednesday to explain what's new in migraine research, treatment and prevention, as well as when you should see a neurologist.

"Migraine can be debilitating. The word we sometimes like to use is even disabling," said Dr. Thomas Berk, a neurologist and headache specialist, is the Medical Director of Neura Health in New York.

Nearly 42 million Americans regularly deal with headaches and migraine attacks, according to the National Headache Foundation, most of them women. If you’re one, you might be used to the ...